Bifidobacterium breve is a probiotic bacterium that has been studied for its beneficial effects on human health. It lives in the intestines and produces lactic and acetic acid in the gut (1). It can also be discovered in both the gastrointestinal tract of adults and infant humans as well as in human breast milk. As people grow older, the overall number of Bifidobacterium breve microorganisms within their gut tends to decline (2). Studies have indicated that it could potentially be beneficial in promoting skin health, relieving allergies, and improving gut health. Additionally, it plays a crucial role in the gut microbiota of infants and can assist in managing issues like constipation and diarrhoea (2).
If you have a weakened immune system, please consult your health care practitioner before using this product.
Epigenetics probiotic Bifidobacterium breve is produced in a vegan friendly and convenient delayed release capsule. Recommended daily dose is 1 serving per day taken after a meal, or as directed by a healthcare practitioner. This product is not intended to be used as an alternative to a varied diet.
||Amount per serving
|Inulin (from Jerusalem artichoke)
||50 mg (5B CFU)
† Percent Daily Reference Intakes (RI) not established.
INGREDIENTS: Organic Jerusalem artichoke tuber extract (Helianthus tuberosus), Delayed release vegetable capsule (Hydroxypropyl methylcellulose, Gellan gum), Bifidobacterium breve.
Suitable for vegans
Bifidobacterium breve can be particularly advantageous for adults due to its potential to enhance skin health. A Japanese research study discovered that fermented milk containing Bifidobacterium breve resulted in improved intestinal and skin health among young female students. The difference in skin clarity between the group consuming probiotics and those who did not was especially noteworthy. It was suggested that regular consumption of probiotic milk may prevent skin dryness, enhance gut function, and aid in the removal of toxins. Furthermore, studies involving mice have revealed that Bifidobacterium breve can help prevent water loss and boost skin elasticity, as well as minimise harm caused by chronic UV exposure (3).
The anti-allergy properties of Bifidobacterium breve can be especially advantageous for children. Studies have demonstrated that administering Bifidobacterium breve to pre-term infants can trigger an anti-inflammatory response, which can help reduce the risk of allergic reactions later in life. Moreover, Bifidobacterium breve can diminish hypersensitivity to cow’s milk and prevent reactions to atopic dermatitis in infants. Another study reported that Bifidobacterium breve can lower the likelihood of children developing skin conditions such as eczema and atopic sensitisation, especially in those who are predisposed to allergies. It may also assist in strengthening the immune system, which can alleviate the symptoms of allergic rhinitis. Research also suggests that regular consumption of Bifidobacterium breve may help suppress the body’s immune response, thereby mitigating allergic reactions. Bifidobacterium breve’s ability to modulate the processes that cause allergy-related asthma attacks and reduce airway inflammation can be especially advantageous for individuals with asthma. Combining the probiotic with certain fructooligosaccharides may also enhance its effectiveness even further (3).
The gut microbiota plays a crucial role in infants, and Bifidobacterium breve has shown promising results in promoting the colonisation of beneficial bacteria and the development of normal intestinal flora in low birth weight infants with no other deformities, chromosomal abnormalities, or intrauterine infections, according to a study of 30 infants. Additionally, in 10 very low birth weight infants, early administration of Bifidobacterium breve resulted in a significant reduction in aspirated air volume and improvement in weight gain. In laboratory settings, Bifidobacterium breve has also demonstrated the ability to inhibit coliforms, indicating its potential to outcompete harmful gut flora (2).
Bifidobacterium breve has shown promise in improving gastrointestinal health in various studies. In one study of 971 healthy young infants, a combination of Bifidobacterium breve and Streptococcus thermophilus was found to alleviate the severity of acute diarrhoea and dehydration. Another study found that Bifidobacterium breve was effective in reducing abdominal pain and increasing stool frequency in 20 children with functional constipation. Likewise, in animal studies, the bacterium demonstrated the ability to reduce the incidence, severity, and duration of diarrhoea in rats with rotavirus infection. These findings suggest that Bifidobacterium breve may have potential as a therapeutic agent for various gastrointestinal disorders (2).
In some cases, Bifidobacterium breve may pose risks for certain individuals. People with weakened immune systems should consult their healthcare practitioner before taking Bifidobacterium breve, Similarly, caution should be exercised when administering Bifidobacterium breve to infants with blockages in the intestines (1).
Packaging: 60 capsules
Recommended daily dose, 1 serving taken after a meal.
Serving size: 1 capsule, Servings per container: 60
Store in a refrigerator out of reach and sight of children. Once opened, consume within 6 months.